Healthgen Biotech Project HY-1003 Obtained the Orphan Drug Designation from U.S. FDA February 19, 2020, the project HY-1003, Recombinant human Alpha-1 Antitrypsin, a new bio-pharmaceutical independently developed by Wuhan Healthgen Biotechnology Corp.( hereinafter referred to as Healthgen Biotech) by its State-of-the-Art plant expression platform, had obtained th... Posted by Site editor|2020-03-25 LearnMore
Healthgen Biotech Has Gained The Clinical Trial License of A New Bio-innovative Drug May 13th, 2020, Wuhan Healthgen Biotechnology Corp.( hereinafter referred to as Healthgen Biotech) received the Clinical Trial Notice of its new bio-innovative drug - Recombinant Human Lactoferrin and Lysozyme Oral Liquid (Project No. HY1002) from the Center for Drug Evaluation o... Posted by Site editor|2020-05-13 LearnMore
The large quantities supply of proteinase K you want is here! What is Proteinase K?   Proteinase K is a broad-spectrum serine protease, its crystallization and molecular structure indicate it belongs to subtilisin family and has no significant substrate specificity. Proteinase K‘s main cleavage site of is the peptide bond a... Posted by Site editor|2020-07-28 LearnMore
Healthgen Biotech project HY1002 clinical trials phase I kick-off meeting was successfully held September 2, 2020, the kick-off meeting of " clinical trials phase I project of recombinant human lactoferrin and lysozyme oral liquid (Project No. HY1002) " was successfully held in the Affiliated Hospital of Guizhou Medical University, marking the official entry of th... Posted by Site editor|2020-09-03 LearnMore
The Starting Ceremony of the Construction of Plant-derived Recombinant Human Serum Albumin of 1 Million Vials Production Line Project   February 19th, 2021, the 8th day of the first lunar year, Wuhan Healthgen Biotechnology Corp. (Hereinafter referred to as "Healthgen Biotech") had the starting ceremony of the construction of plant-derived recombinant human serum albumin core technology resear... Posted by Site editor|2021-02-19 LearnMore
Pre 1 2 3 4 5 Next

Wuhan Healthgen Biotechnology Corp.

Tel. +86 027 59301891 Ext 8015

Fax. +86 027 59403931

E-mail cjing@oryzogen.com

268 Shendun 5th Road, East Lake High-Tech Development Zone, Wuhan, China 430020

Copyright ® Wuhan Healthgen Biotechnology Corp. All rights reserved. Terms and Conditions of Use
鄂ICP备12013293号-3